Gastroesophageal Reflux Disease (GERD) Market Size, Share, and Outlook, H2-2025 Report- By Diagnosis (Upper Endoscopy, Ambulatory Acid (pH) Probe Test, Esophageal Manometry, Others), By Drug (Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, Others) an
Description
Gastroesophageal Reflux Disease (GERD) Market Outlook
The global Gastroesophageal Reflux Disease (GEThe GERD market encompasses pharmacological and device-based interventions to manage chronic reflux of stomach contents into the esophagus. Proton pump inhibitors (PPIs) remain a cornerstone therapy, alongside H2 receptor antagonists and prokinetic agents, although long-term use of PPIs is under scrutiny due to potential side effects. Minimally invasive surgical procedures, such as laparoscopic fundoplication, and newer endoscopic approaches like magnetic sphincter augmentation, offer alternatives for patients unresponsive to medication. Advances in pH monitoring, impedance testing, and diagnostic imaging are improving the accuracy of GERD diagnosis and enabling targeted therapy. Lifestyle modification programs, including diet changes and weight management, remain complementary strategies to medical or surgical treatment. Rising obesity rates, aging populations, and dietary shifts in emerging economies are contributing to a growing patient pool. Recent pharmaceutical research focuses on potassium-competitive acid blockers (P-CABs), which offer faster symptom relief compared to traditional PPIs. Telemedicine platforms are enabling remote GERD symptom tracking and treatment adherence monitoring. Market growth is influenced by both consumer demand for rapid symptom relief and physician emphasis on reducing long-term complications such as Barrett’s esophagus.) Market Size is valued at $5.3 Billion in 2025 and is forecast to reach $7 Billion in 2032 at a CAGR of 4.1%.
The Gastroesophageal Reflux Disease (GERD) Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Gastroesophageal Reflux Disease (GERD) Market segments across 22 countries from 2021 to 2032. Key segments covered include By Diagnosis (Upper Endoscopy, Ambulatory Acid (pH) Probe Test, Esophageal Manometry, Others), By Drug (Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Gastroesophageal Reflux Disease (GERD) Market Insights, 2025
The GERD market encompasses pharmacological and device-based interventions to manage chronic reflux of stomach contents into the esophagus. Proton pump inhibitors (PPIs) remain a cornerstone therapy, alongside H2 receptor antagonists and prokinetic agents, although long-term use of PPIs is under scrutiny due to potential side effects. Minimally invasive surgical procedures, such as laparoscopic fundoplication, and newer endoscopic approaches like magnetic sphincter augmentation, offer alternatives for patients unresponsive to medication. Advances in pH monitoring, impedance testing, and diagnostic imaging are improving the accuracy of GERD diagnosis and enabling targeted therapy. Lifestyle modification programs, including diet changes and weight management, remain complementary strategies to medical or surgical treatment. Rising obesity rates, aging populations, and dietary shifts in emerging economies are contributing to a growing patient pool. Recent pharmaceutical research focuses on potassium-competitive acid blockers (P-CABs), which offer faster symptom relief compared to traditional PPIs. Telemedicine platforms are enabling remote GERD symptom tracking and treatment adherence monitoring. Market growth is influenced by both consumer demand for rapid symptom relief and physician emphasis on reducing long-term complications such as Barrett’s esophagus.
Five Trends Shaping the Global Gastroesophageal Reflux Disease (GERD) Market in 2025 and Beyond
The global Gastroesophageal Reflux Disease (GERD) Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Gastroesophageal Reflux Disease (GERD) Industry?
The Gastroesophageal Reflux Disease (GERD) Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Gastroesophageal Reflux Disease (GERD) Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Gastroesophageal Reflux Disease (GERD) Market Segment Insights
The Gastroesophageal Reflux Disease (GERD) Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Diagnosis (Upper Endoscopy, Ambulatory Acid (pH) Probe Test, Esophageal Manometry, Others), By Drug (Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Gastroesophageal Reflux Disease (GERD) Industry Value Chain
The chapter identifies potential companies and their operations across the global Gastroesophageal Reflux Disease (GERD) Industry ecosystem. It assists decision-makers in evaluating global Gastroesophageal Reflux Disease (GERD) Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Gastroesophageal Reflux Disease (GERD) Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Gastroesophageal Reflux Disease (GERD) Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Gastroesophageal Reflux Disease (GERD) Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Gastroesophageal Reflux Disease (GERD) Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Gastroesophageal Reflux Disease (GERD) Market.
Europe Gastroesophageal Reflux Disease (GERD) Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Gastroesophageal Reflux Disease (GERD) Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Gastroesophageal Reflux Disease (GERD) Industry competitiveness. The report analyses the key Gastroesophageal Reflux Disease (GERD) Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Gastroesophageal Reflux Disease (GERD) Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Gastroesophageal Reflux Disease (GERD) Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Gastroesophageal Reflux Disease (GERD) Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Gastroesophageal Reflux Disease (GERD) Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Gastroesophageal Reflux Disease (GERD) Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Gastroesophageal Reflux Disease (GERD) Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AstraZeneca Plc, Aurobindo Pharma, Glenmark, Haleon Group of Companies , Johnson & Johnson, Medtronic Plc, Pfizer Inc, Reckitt Benckiser Group PLC, SRS Life Sciences, Takeda Pharmaceutical Co. Ltd, Teva Pharmaceuticals Industries Ltd, TWi Pharmaceuticals Inc, Zydus Group. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Gastroesophageal Reflux Disease (GERD) Market Scope
Leading Segments
By Diagnosis
Upper Endoscopy
Ambulatory Acid (pH) Probe Test
Esophageal Manometry
Others
By Drug
Proton Pump Inhibitors (PPIs)
H2 Receptor Blockers
Others
Leading Companies
AstraZeneca Plc
Aurobindo Pharma
Glenmark
Haleon Group of Companies
Johnson & Johnson
Medtronic Plc
Pfizer Inc
Reckitt Benckiser Group PLC
SRS Life Sciences
Takeda Pharmaceutical Co. Ltd
Teva Pharmaceuticals Industries Ltd
TWi Pharmaceuticals Inc
Zydus Group
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Gastroesophageal Reflux Disease (GEThe GERD market encompasses pharmacological and device-based interventions to manage chronic reflux of stomach contents into the esophagus. Proton pump inhibitors (PPIs) remain a cornerstone therapy, alongside H2 receptor antagonists and prokinetic agents, although long-term use of PPIs is under scrutiny due to potential side effects. Minimally invasive surgical procedures, such as laparoscopic fundoplication, and newer endoscopic approaches like magnetic sphincter augmentation, offer alternatives for patients unresponsive to medication. Advances in pH monitoring, impedance testing, and diagnostic imaging are improving the accuracy of GERD diagnosis and enabling targeted therapy. Lifestyle modification programs, including diet changes and weight management, remain complementary strategies to medical or surgical treatment. Rising obesity rates, aging populations, and dietary shifts in emerging economies are contributing to a growing patient pool. Recent pharmaceutical research focuses on potassium-competitive acid blockers (P-CABs), which offer faster symptom relief compared to traditional PPIs. Telemedicine platforms are enabling remote GERD symptom tracking and treatment adherence monitoring. Market growth is influenced by both consumer demand for rapid symptom relief and physician emphasis on reducing long-term complications such as Barrett’s esophagus.) Market Size is valued at $5.3 Billion in 2025 and is forecast to reach $7 Billion in 2032 at a CAGR of 4.1%.
The Gastroesophageal Reflux Disease (GERD) Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Gastroesophageal Reflux Disease (GERD) Market segments across 22 countries from 2021 to 2032. Key segments covered include By Diagnosis (Upper Endoscopy, Ambulatory Acid (pH) Probe Test, Esophageal Manometry, Others), By Drug (Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Gastroesophageal Reflux Disease (GERD) Market Insights, 2025
The GERD market encompasses pharmacological and device-based interventions to manage chronic reflux of stomach contents into the esophagus. Proton pump inhibitors (PPIs) remain a cornerstone therapy, alongside H2 receptor antagonists and prokinetic agents, although long-term use of PPIs is under scrutiny due to potential side effects. Minimally invasive surgical procedures, such as laparoscopic fundoplication, and newer endoscopic approaches like magnetic sphincter augmentation, offer alternatives for patients unresponsive to medication. Advances in pH monitoring, impedance testing, and diagnostic imaging are improving the accuracy of GERD diagnosis and enabling targeted therapy. Lifestyle modification programs, including diet changes and weight management, remain complementary strategies to medical or surgical treatment. Rising obesity rates, aging populations, and dietary shifts in emerging economies are contributing to a growing patient pool. Recent pharmaceutical research focuses on potassium-competitive acid blockers (P-CABs), which offer faster symptom relief compared to traditional PPIs. Telemedicine platforms are enabling remote GERD symptom tracking and treatment adherence monitoring. Market growth is influenced by both consumer demand for rapid symptom relief and physician emphasis on reducing long-term complications such as Barrett’s esophagus.
Five Trends Shaping the Global Gastroesophageal Reflux Disease (GERD) Market in 2025 and Beyond
The global Gastroesophageal Reflux Disease (GERD) Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Gastroesophageal Reflux Disease (GERD) Industry?
The Gastroesophageal Reflux Disease (GERD) Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Gastroesophageal Reflux Disease (GERD) Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Gastroesophageal Reflux Disease (GERD) Market Segment Insights
The Gastroesophageal Reflux Disease (GERD) Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Diagnosis (Upper Endoscopy, Ambulatory Acid (pH) Probe Test, Esophageal Manometry, Others), By Drug (Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Gastroesophageal Reflux Disease (GERD) Industry Value Chain
The chapter identifies potential companies and their operations across the global Gastroesophageal Reflux Disease (GERD) Industry ecosystem. It assists decision-makers in evaluating global Gastroesophageal Reflux Disease (GERD) Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Gastroesophageal Reflux Disease (GERD) Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Gastroesophageal Reflux Disease (GERD) Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Gastroesophageal Reflux Disease (GERD) Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Gastroesophageal Reflux Disease (GERD) Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Gastroesophageal Reflux Disease (GERD) Market.
Europe Gastroesophageal Reflux Disease (GERD) Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Gastroesophageal Reflux Disease (GERD) Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Gastroesophageal Reflux Disease (GERD) Industry competitiveness. The report analyses the key Gastroesophageal Reflux Disease (GERD) Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Gastroesophageal Reflux Disease (GERD) Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Gastroesophageal Reflux Disease (GERD) Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Gastroesophageal Reflux Disease (GERD) Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Gastroesophageal Reflux Disease (GERD) Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Gastroesophageal Reflux Disease (GERD) Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Gastroesophageal Reflux Disease (GERD) Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes AstraZeneca Plc, Aurobindo Pharma, Glenmark, Haleon Group of Companies , Johnson & Johnson, Medtronic Plc, Pfizer Inc, Reckitt Benckiser Group PLC, SRS Life Sciences, Takeda Pharmaceutical Co. Ltd, Teva Pharmaceuticals Industries Ltd, TWi Pharmaceuticals Inc, Zydus Group. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Gastroesophageal Reflux Disease (GERD) Market Scope
Leading Segments
By Diagnosis
Upper Endoscopy
Ambulatory Acid (pH) Probe Test
Esophageal Manometry
Others
By Drug
Proton Pump Inhibitors (PPIs)
H2 Receptor Blockers
Others
Leading Companies
AstraZeneca Plc
Aurobindo Pharma
Glenmark
Haleon Group of Companies
Johnson & Johnson
Medtronic Plc
Pfizer Inc
Reckitt Benckiser Group PLC
SRS Life Sciences
Takeda Pharmaceutical Co. Ltd
Teva Pharmaceuticals Industries Ltd
TWi Pharmaceuticals Inc
Zydus Group
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
182 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Gastroesophageal Reflux Disease (GERD) Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Gastroesophageal Reflux Disease (GERD) Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Gastroesophageal Reflux Disease (GERD) Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Gastroesophageal Reflux Disease (GERD) Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Gastroesophageal Reflux Disease (GERD) Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Diagnosis
- Upper Endoscopy
- Ambulatory Acid (pH) Probe Test
- Esophageal Manometry
- Others
- By Drug
- Proton Pump Inhibitors (PPIs)
- H2 Receptor Blockers
- Others
- 6. Global Gastroesophageal Reflux Disease (GERD) Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Gastroesophageal Reflux Disease (GERD) Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Gastroesophageal Reflux Disease (GERD) Market Trends and Growth Opportunities
- 6.2.1 North America Gastroesophageal Reflux Disease (GERD) Market Outlook by Type
- 6.2.2 North America Gastroesophageal Reflux Disease (GERD) Market Outlook by Application
- 6.3 North America Gastroesophageal Reflux Disease (GERD) Market Outlook by Country
- 6.3.1 The US Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 6.3.2 Canada Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 6.3.3 Mexico Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 7. Europe Gastroesophageal Reflux Disease (GERD) Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Gastroesophageal Reflux Disease (GERD) Market Trends and Growth Opportunities
- 7.2.1 Europe Gastroesophageal Reflux Disease (GERD) Market Outlook by Type
- 7.2.2 Europe Gastroesophageal Reflux Disease (GERD) Market Outlook by Application
- 7.3 Europe Gastroesophageal Reflux Disease (GERD) Market Outlook by Country
- 7.3.2 Germany Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 7.3.3 France Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 7.3.4 The UK Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 7.3.5 Spain Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 7.3.6 Italy Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 7.3.7 Russia Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 8. Asia Pacific Gastroesophageal Reflux Disease (GERD) Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Gastroesophageal Reflux Disease (GERD) Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Gastroesophageal Reflux Disease (GERD) Market Outlook by Type
- 8.2.2 Asia Pacific Gastroesophageal Reflux Disease (GERD) Market Outlook by Application
- 8.3 Asia Pacific Gastroesophageal Reflux Disease (GERD) Market Outlook by Country
- 8.3.1 China Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 8.3.2 India Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 8.3.3 Japan Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 8.3.4 South Korea Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 8.3.5 Australia Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 8.3.6 South East Asia Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 9. South America Gastroesophageal Reflux Disease (GERD) Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Gastroesophageal Reflux Disease (GERD) Market Trends and Growth Opportunities
- 9.2.1 South America Gastroesophageal Reflux Disease (GERD) Market Outlook by Type
- 9.2.2 South America Gastroesophageal Reflux Disease (GERD) Market Outlook by Application
- 9.3 South America Gastroesophageal Reflux Disease (GERD) Market Outlook by Country
- 9.3.1 Brazil Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 9.3.2 Argentina Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 10. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Market Outlook by Type
- 10.2.2 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Market Outlook by Application
- 10.3 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Market Outlook by Country
- 10.3.1 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 10.3.2 The UAE Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 10.3.4 South Africa Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 10.3.5 Egypt Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Gastroesophageal Reflux Disease (GERD) Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- AstraZeneca Plc
- Aurobindo Pharma
- Glenmark
- Haleon Group of Companies
- Johnson & Johnson
- Medtronic Plc
- Pfizer Inc
- Reckitt Benckiser Group PLC
- SRS Life Sciences
- Takeda Pharmaceutical Co. Ltd
- Teva Pharmaceuticals Industries Ltd
- TWi Pharmaceuticals Inc
- Zydus Group
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
